Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,164,912 papers from all fields of science
Search
Sign In
Create Free Account
Duolip
Known as:
Merckle brand of etofyllinclofibrate
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
etofylline clofibrate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
[Use of etofyllinclofibrate (Duolip Forte) in combined hyperlipidemia].
J. Hrebícek
,
N. Škottová
,
Z. Chmela
,
M. Hrbkova
Casopis lekaru ceskych
1995
Corpus ID: 32515519
BACKGROUND Duolip forte (ethophyllinclofibrate) is a lipid lowering drug, the effect of which was not yet adequately verified in…
Expand
1993
1993
[Therapy with fibrates and vitamin D metabolism].
H. Wilczek
,
J. Šobra
,
+4 authors
Z. Juzova
Casopis lekaru ceskych
1993
Corpus ID: 8557437
The authors investigated in 29 patients with familial hyperlipoproteinaemia the effect of fibrate treatment (Duolip forte…
Expand
1993
1993
[Duolip Forte--experience during a 6-month period of administration].
H. Toschnerová
,
R. Češka
,
J. Šobra
,
J. Traurig
Casopis lekaru ceskych
1993
Corpus ID: 33050269
Duolip forte (ethophylline clofibrate, tablets à 500 mg) produced by Merckle Austria was administered to 20 patients with…
Expand
1986
1986
Effect of etofylline clofibrate on experimental thrombus formation and prostacyclin activation.
G. Metz
,
A. Sim
,
A. McCraw
,
M. E. Cleland
Arzneimittel-Forschung
1986
Corpus ID: 3067490
1-(7-Theophyllinyl)-2-ethyl-[2-(p-chlorophenoxy)-isobutyrate] (etofylline clofibrate, theofibrate, Duolip) was shown to possess…
Expand
1983
1983
[Modification of serum uric acid concentration under long-term therapy with the lipid-regulating drug Duolip].
R. Scherhag
Fortschritte der Medizin
1983
Corpus ID: 39248578
During an 8-months treatment period the effect of Duolip on serum uric acid in 112 patients with hyperlipidemia was studied. In…
Expand
1980
1980
Biopharmaceutic evaluation of etofylline clofibrate and its drug formulation.
Wolfgang A. Ritschel
,
Thompson Ga
,
Lücker Pw
,
K. Wetzelsberger
Arzneimittel-Forschung
1980
Corpus ID: 24221556
The biopharmaceutic criteria of Duolip and its active principle, 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2…
Expand
1980
1980
[Pharmacology and toxicology of etofylline clofibrate].
W. Sterner
,
W. Korn
Arzneimittel-Forschung
1980
Corpus ID: 24768452
1-(Theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate, ML 1024, Duolip) was investigated…
Expand
1980
1980
Effect of etofylline clofibrate on experimental thrombosis and platelet function.
A. Sim
,
M. Davies
,
A. McCraw
,
G. Metz
Arzneimittel-Forschung
1980
Corpus ID: 23100571
1-(Theophyllin-7yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate, ML 1024, Duolip) was shown to be a…
Expand
1980
1980
[Effect of etofylline clofibrate on the composition of lipoproteins in hyperlipidaemia type IIb and IV (author's transl)].
H. Ditschuneit
,
V. Hutt
,
H. Klör
,
H. Ditschuneit
Arzneimittel-Forschung
1980
Corpus ID: 7802645
Efficacy of 1-(theophyllin-7-yl)-ethyl-2[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate, Duolip) (3 x 250 mg) was…
Expand
1980
1980
[Chemistry of phenoxyacetic acid esters of oxyalkyltheophyllines and 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methyl-propionate] (etofylline clofibrate), a novel antilipaemic agent (author…
G. Metz
,
M. Specker
Arzneimittel-Forschung
1980
Corpus ID: 21309672
Esters of phenoxyacetic acids and oxyalkyltheophyllines were prepared as potential antihyperlipaemics. The basic idea was to…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE